### Claims-to-Experiments Mapping
- Claim: LiSeCo reduces toxicity/negativity while maintaining naturalness better than ActAdd and on-par with instruction tuning. (Supported by Figure 3 and Figure 4).
- Claim: The parameter `p` tracks the fraction of toxic labels. (Supported by Figure 4, though weakly).

### Baseline Assessment
- **Strength & Fairness:** The baselines are unfairly tuned. For Activation Addition (ActAdd), the authors "perform a coarse-grained hyperparameter grid search on the intervention layer l" searching among `{6, 15, 24}`. This means ActAdd is restricted to a **single layer**. In contrast, LiSeCo intervenes at **every layer** (`t=1...T`). Comparing a single-layer intervention against a full-depth 32-layer continuous intervention is fundamentally unfair. Furthermore, ActAdd is only applied to the first token position ("we apply the intervention at the first token position", Line 1276), while LiSeCo is applied at every generation step.

### Dataset Assessment
- **Relevance:** Jigsaw and RealToxicityPrompts are standard. 
- **Size (CRITICAL FLAW):** The sample size for the evaluation is unacceptably small. The authors state (Line 466): "N = 25, 37, 37 for Llama, Mistral, and Pythia, respectively". This means the entire toxicity reduction evaluation is based on **25 prompts** for Llama. 

### Metric Assessment
- **Completeness:** External toxicity scorer and human naturalness are appropriate. Perplexity was discarded due to low correlation with naturalness.

### Statistical Rigor
- **Variance reporting:** Reporting percentage metrics over 25 samples is highly misleading. 1 out of 25 is 4%. When Figure 4 shows a difference between 29% and 25%, this literally represents a difference of **one single generation** (7/25 vs 6/25). Claiming that `p` smoothly controls toxicity based on 1-sample fluctuations is statistically invalid. There is absolutely no statistical significance to the differences between the LiSeCo configurations on such a tiny dataset.

### Ablation Assessment
- No meaningful ablation of the layer-wise application. What happens if LiSeCo is only applied at a single layer (like the ActAdd baseline)?

### Missing Experiments
- Evaluation on a statistically significant sample size (e.g., N=1000).
- Fair comparison where ActAdd is applied at every layer and every token, matching LiSeCo's budget.

### Overall Experimental Rigor Verdict
Fundamentally flawed. Evaluating generative interventions on a test set of N=25 samples and interpreting 1-sample differences as meaningful trends completely undermines the empirical claims. Combined with the unfair baseline implementations, the experiments do not rigorously support the paper's conclusions.